Clinical Trial Update: Non-invasive Imaging With [18F]VM4-037 [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial of the PET imaging agent [18F]VM4-037 was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• [18F]VM4-037 (VM4-037)

Snippet

Sponsor: Maastricht Radiation Oncology | Conditions: Stage 4 Cancer | Phase 1 | Status: WITHDRAWN